NCT00314704View on ClinicalTrials.gov

Dopamine and Norepinephrine in Shock Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,679

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Shock
Interventions
DRUG

dopamine versus norepinephrine

Trial Locations (8)

1000

CHU Saint Pierre, Brussels

1020

CHU Brugmann, Brussels

1050

HIS Ixelles, Brussels

1070

Erasme University Hospital, Brussels

1090

University Hospital of Vienna, Vienna

1180

St Elisabeth, Brussels

6000

CHU Charleroi, Charleroi

47002

Hospital Universitario Rio Hortega, Valladolid

All Listed Sponsors
lead

Sepsis Occurrence in Acutely Ill Patients

OTHER

NCT00314704 - Dopamine and Norepinephrine in Shock Patients | Biotech Hunter | Biotech Hunter